Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Schweiz Arch Tierheilkd ; 157(6): 319-28, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26753347

ABSTRACT

Listeria (L.) monocytogenes is widely distributed in the environment, but also has the ability to cause serious invasive disease in ruminants and humans. This review provides an overview of listeriosis in ruminants and discusses our insufficient understanding of reservoirs and possible cycling ofL. monocytogenes between animal and human hosts, food and the environment. It indicates gaps in our knowledge of the role of genetic subtypes in L. monocytogenes ecology and virulence as well as risk factors, in vivo diagnostics and pathogenesis of listeriosis in ruminants. Filling these gaps will contribute to improving the control of L. monocytogenes and enhancing disease prevention. As the prevalence of listeriosis in ruminants in Switzerland is likely to be underestimated, propositions concerning improvement options for surveillance of listeriosis in ruminants are provided.


Subject(s)
Disease Reservoirs , Environmental Microbiology , Food Microbiology , Listeriosis/veterinary , Ruminants , Zoonoses , Animals , Central Nervous System Bacterial Infections/epidemiology , Central Nervous System Bacterial Infections/therapy , Central Nervous System Bacterial Infections/transmission , Central Nervous System Bacterial Infections/veterinary , Humans , Listeria monocytogenes/classification , Listeria monocytogenes/genetics , Listeria monocytogenes/physiology , Listeriosis/epidemiology , Listeriosis/etiology , Listeriosis/therapy , Population Surveillance , Switzerland/epidemiology , Zoonoses/epidemiology , Zoonoses/transmission
2.
Int J Cosmet Sci ; 34(4): 328-31, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22515301

ABSTRACT

Skin over-hydration is a common problem that affects many people who wear incontinence pads or diapers. The aim of this study is to develop a new method for stratum corneum (SC) over-hydration and SC water diffusion coefficient measurements using opto-thermal transient emission radiometry (OTTER) and evaporimetry. With OTTER, we can measure the SC surface hydration and hydration gradient. With evaporimetry, we can measure the time-dependent evaporative drying curves of water vapour flux density (WVFD). The combination of hydration results and WVFD results can yield information on the SC water diffusion coefficient and how it depends on the SC surface hydration level. The results show that SC water diffusion coefficient is non-linearly proportional to the SC surface hydration level. The results also show strong correlations between evaporative drying flux measured using the Evaporimeter and surface hydration estimated from OTTER measurements.


Subject(s)
Skin/metabolism , Water/metabolism , Adult , Female , Humans , Radiometry/methods , Skin/chemistry , Water/analysis , Young Adult
3.
Int J Pharm ; 406(1-2): 111-3, 2011 Mar 15.
Article in English | MEDLINE | ID: mdl-21251961

ABSTRACT

This work describes the first application of Opto-Thermal Transient Emission Radiometry (OTTER), an infrared remote sensing technique, to probe the extent to which solvents permeate the human nail in vivo. Decanol, glycerol and butyl acetate were selected as model solvents. After application of the solvents, individually, to human volunteers, OTTER was used to depth profile the solvents. The permeation rate of the solvents was ranked as glycerol>decanol>butyl acetate. It is possible that some of the butyl acetate may have evaporated during the experiment. The ability of decanol to extract lipids from biological tissue is also considered. These preliminary results demonstrate the potential of OTTER as a tool to identify optimal excipients with which to target drugs to the nail.


Subject(s)
Diagnostic Imaging/methods , Nails/metabolism , Pharmaceutical Preparations/administration & dosage , Pharmaceutical Vehicles/pharmacokinetics , Solvents/pharmacokinetics , Acetates/chemistry , Alcohols/chemistry , Diagnostic Imaging/instrumentation , Diffusion , Hot Temperature , Humans , Lasers , Permeability
4.
Int J Cosmet Sci ; 31(2): 97-118, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19175433

ABSTRACT

The importance of transepidermal water loss (TEWL) as a measure of the skin barrier is well recognized. Currently, the open-chamber method is dominant, but it is increasingly challenged by newer closed-chamber technologies. Whilst there is familiarity with open-chamber characteristics, there is uncertainty about the capabilities of the challengers. The main issues are related to how microclimate affects TEWL measurements. The aim of this paper is to provide a framework for understanding the effects of microclimate on TEWL measurement. Part of the problem is that TEWL measurement is indirect. TEWL is the diffusion of condensed water through the stratum corneum (SC), whereas TEWL methods measure water vapour flux in the air above the SC. This vapour flux depends on (i) the rate of supply of water to the skin surface and (ii) the rate of evaporation of water from the skin surface. Rate (i) is a skin property (TEWL), rate (ii) is a microclimate property. The controlling rate for the combined process is the lower of the above two rates. Therefore, TEWL instruments measure TEWL only when TEWL is the rate-limiting process. Another problem is that SC barrier property and SC hydration are affected by the microclimate adjacent to the skin surface. This is discussed insofar as it affects the measurement of TEWL. The conclusion is that such changes occur on a timescale that is long compared with TEWL measurement times. An important aspect of TEWL measurement is calibration. We present an analysis of the traditional wet-cup method and a new droplet method that is traceable and has been independently verified by a standards laboratory. Finally, we review performance indicators of commercial closed-chamber instruments with reference to open-chamber instruments. The main findings are that TEWL readings correlate well, but there are significant differences in the other aspects of performance.


Subject(s)
Skin Physiological Phenomena , Water Loss, Insensible/physiology , Calibration , Dermatology/instrumentation , Dermatology/methods , Humans , Microclimate
5.
J Med Ethics ; 34(11): 810-4, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18974416

ABSTRACT

BACKGROUND: In Switzerland, non-medical right-to-die organisations such as Exit Deutsche Schweiz and Dignitas offer suicide assistance to members suffering from incurable diseases. OBJECTIVES: First, to determine whether differences exist between the members who received assistance in suicide from Exit Deutsche Schweiz and Dignitas. Second, to investigate whether the practices of Exit Deutsche Schweiz have changed since the 1990s. METHODS: This study analysed all cases of assisted suicide facilitated by Exit Deutsche Schweiz (E) and Dignitas (D) between 2001 and 2004 and investigated by the University of Zurich's Institute of Legal Medicine (E: n = 147; D: n = 274, total: 421). Furthermore, data from the Exit Deutsche Schweiz study which investigated all cases of assisted suicide during the period 1990-2000 (n = 149) were compared with the data of the present study. RESULTS: More women than men were assisted in both organisations (D: 64%; E: 65%). Dignitas provided more assistance to non-residents (D: 91%; E: 3%; p = 0.000), younger persons (mean age in years (SD): D: 64.5 (14.1); E: 76.6 (13.3); p = 0.001), and people suffering from fatal diseases such as multiple sclerosis and amyotrophic lateral sclerosis (D: 79%; E: 67%; p = 0.013). Lethal medications were more often taken orally in cases assisted by Dignitas (D: 91%; E: 76%; p = 0.000). The number of women and the proportion of older people suffering from non-fatal diseases among suicides assisted by Exit Deutsche Schweiz has increased since the 1990s (women: 52% to 65%, p = 0.031; mean age in years (SD): 69.3 (17.0) to 76.9 (13.3), p = 0.000), non-fatal diseases: 22% to 34%, p = 0.026). CONCLUSIONS: Weariness of life rather than a fatal or hopeless medical condition may be a more common reason for older members of Exit Deutsche Schweiz to commit suicide. The strong over-representation of women in both Exit Deutsche Schweiz and Dignitas suicides is an important phenomenon so far largely overlooked and in need of further study.


Subject(s)
Organizations/statistics & numerical data , Suicide, Assisted/statistics & numerical data , Adult , Aged , Aged, 80 and over , Drug Administration Routes , Female , Humans , Male , Middle Aged , Right to Die , Sex Factors , Suicide, Assisted/ethnology , Suicide, Assisted/trends , Switzerland
6.
Euro Surveill ; 13(37)2008 Sep 11.
Article in English | MEDLINE | ID: mdl-18801315

ABSTRACT

Salmonella serovar Stanley is rare in Europe. In Switzerland, the number of reported isolates has increased from 2 in 2000 to 25 in 2005. A nationwide outbreak of gastrointestinal illness due to S. Stanley occurred from September 2006 through February 2007. Eighty-two cases were documented. Males were 56%; mean age of the cases was 45.7 years (range 0-92). Forty-seven cases (57%) occurred in three western cantons: Vaud, Bern, and Geneva. Twenty-three cases (28%) were hospitalised. In the case-control study conducted to find the source of the outbreak, cases were more likely than controls to have eaten local soft cheese (OR 11.4, p=0.008). One clone of S. Stanley strain was isolated from soft cheese and from 77 cases (94%) who reported no history of having travelled abroad. The outbreak ended after the withdrawal of the cheese from the market. This is the first S. Stanley outbreak in Switzerland and the first in Europe unrelated to imported products, suggesting an increased local circulation of this previously rare serotype.


Subject(s)
Cheese/microbiology , Disease Outbreaks , Salmonella Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/epidemiology , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Salmonella/isolation & purification , Switzerland/epidemiology
7.
J Biol Chem ; 276(49): 45588-97, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11590148

ABSTRACT

Poly(ADP-ribose) polymerase 1 (PARP-1)-deficient mice are protected against septic shock, diabetes type I, stroke, and inflammation. We report that primary cells from PARP-1(-/-) animals are impaired in kappa B-dependent transcriptional activation induced by different stimuli involved in inflammatory and genotoxic stress signaling. PARP-1 was also required for p65-mediated transcriptional activation. PARP-1 enzymatic inhibitors did not inhibit the transcriptional activation of a kappa B-dependent reporter gene in wild type cells. Remarkably, neither the enzymatic activity nor the DNA binding activity of PARP-1 was required for kappa B-dependent transcriptional activation in PARP-1(-/-) cells complemented with different PARP-1 mutants. However, PARP-1 interacted in vitro directly with both subunits of NF-kappa B (p50 and p65), and mapping of the interaction domains revealed that both subunits bind to different PARP-1 domains. Furthermore, a PARP-1 mutant lacking the enzymatic and DNA binding activity interacted comparably to the wild type PARP-1 with p65 or p50. Finally, we showed that PARP-1 is activating the natural inducible nitric-oxide synthase and P-selectin promoter in a kappa B-dependent manner upon stimulation of the cells with inflammatory stimuli or cotransfection of p65. Our results provide evidence that neither the DNA binding nor the enzymatic activity of PARP-1 but its direct protein-protein interaction with both subunits of NF-kappa B is required for its coactivator function, thus expanding the role of PARP-1 as an essential and novel classical transcriptional coactivator for kappa B-dependent gene expression in vivo.


Subject(s)
NF-kappa B/metabolism , Poly(ADP-ribose) Polymerases/metabolism , B-Lymphocytes/metabolism , Base Sequence , Binding Sites , Cell Line , DNA Primers , Enzyme Activation , Humans , Inflammation Mediators/pharmacology , Mutagens/pharmacology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , P-Selectin/genetics , Poly(ADP-ribose) Polymerase Inhibitors , Promoter Regions, Genetic , Protein Binding , T-Lymphocytes/metabolism , Transcription, Genetic
8.
Mol Cell ; 7(6): 1221-31, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11430825

ABSTRACT

We describe a role for the transcriptional coactivator p300 in DNA metabolism. p300 formed a complex with flap endonuclease-1 (Fen1) and acetylated Fen1 in vitro. Furthermore, Fen1 acetylation was observed in vivo and was enhanced upon UV treatment of human cells. Remarkably, acetylation of the Fen1 C terminus by p300 significantly reduced Fen1's DNA binding and nuclease activity. Proliferating cell nuclear antigen (PCNA) was able to stimulate both acetylated and unacetylated Fen1 activity to the same extent. Our results identify acetylation as a novel regulatory modification of Fen1 and implicate that p300 is not only a component of the chromatin remodeling machinery but might also play a critical role in regulating DNA metabolic events.


Subject(s)
Endodeoxyribonucleases/genetics , Endodeoxyribonucleases/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism , Transcriptional Activation/physiology , Acetylation/radiation effects , Amino Acid Sequence , Binding Sites , Chromatin/metabolism , DNA/metabolism , Endodeoxyribonucleases/chemistry , Flap Endonucleases , HeLa Cells , Humans , In Vitro Techniques , Lysine/metabolism , Molecular Sequence Data , Nuclear Proteins/chemistry , Proliferating Cell Nuclear Antigen/metabolism , Protein Structure, Tertiary , Trans-Activators/chemistry , Ultraviolet Rays
9.
Nature ; 410(6826): 387-91, 2001 Mar 15.
Article in English | MEDLINE | ID: mdl-11268218

ABSTRACT

The transcriptional coactivator p300 interacts with many transcription factors that participate in a broad spectrum of biological activities, such as cellular differentiation, homeostasis and growth control. Mouse embryos lacking both p300 alleles die around mid-gestation, with pleiotropic defects in morphogenesis, in cell differentiation and, unexpectedly, in cell proliferation because of reduced DNA synthesis. Here we show that p300 may have a role in DNA repair synthesis through its interaction with proliferating cell nuclear antigen (PCNA). We show that in vitro and in vivo p300 forms a complex with PCNA that does not depend on the S phase of cell cycle. A large fraction of both p300 and PCNA colocalize to speckled structures in the nucleus. Furthermore, the endogenous p300-PCNA complex stimulates DNA synthesis in vitro. Chromatin immunoprecipitation experiments indicate that p300 is associated with freshly synthesized DNA after ultraviolet irradiation. Our results suggest that p300 may participate in chromatin remodelling at DNA lesion sites to facilitate PCNA function in DNA repair synthesis.


Subject(s)
DNA Repair , DNA/biosynthesis , Nuclear Proteins/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Trans-Activators/metabolism , Animals , Binding Sites , Cell Cycle , Chromatin/metabolism , E1A-Associated p300 Protein , HeLa Cells , Humans , Mice , Mutation , Precipitin Tests , Proliferating Cell Nuclear Antigen/genetics , Protein Binding , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
11.
Eur J Biochem ; 236(3): 996-1002, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8665924

ABSTRACT

The structural features of the active site of human monoamine oxidase B (MAO-B) were investigated by affinity labeling and site-directed mutagenesis. The pseudosubstrate inhibitor N-[2-aminoethyl]-5-chloro-2-pyridine carboxamide HCl (lazabemide) can be irreversibly linked to MAO-B by reduction of the enzyme-inhibitor complex with NaBH(3)CN. Analysis of the flavin spectrum of [(3)H]lazabemide-labeled human MAO-B indicated that insertion of the inhibitor did not occur into the isoalloxazine ring of FAD. After trypsin digestion and HPLC peptide mapping of the radiolabeled enzyme, two labeled peptides were observed. Sequence analysis showed that both peptides started at Val371 of human MAO-B. These results indicate that [(3)H]lazabemide is incorporated into the MAO-B peptide stretch containing the FAD-modified Cys397. The function of putative active-site residues contained in this region was investigated by site-directed mutagenesis and expression of the mutant proteins in HEK-293 cells. Substitution of His382 of MAO-B with an Arg greatly reduced the enzymic activity, suggesting that this residue may represent a nucleophile relevant for the MAO-B catalytic mechanism. Whereas it has been shown that mutation of Cys389 with a Ser residue does not markedly affect the activity of the enzyme [Wu, H.-F., Chen, K. and Shih, J.C. (1993) Mol. Pharmacol. 43, 888-893] the mutant carrying an Ala at this position was virtually inactive. Conversely, substitution of Lys386 (to Met) and Ser394 (to Ala) did not markedly modify the kinetic properties of the enzyme. We also report that mutation of MAO-B Thr158 (to Ala) resulted in a dramatic loss of enzymic activity.


Subject(s)
Affinity Labels , Isoenzymes/chemistry , Isoenzymes/metabolism , Monoamine Oxidase Inhibitors/metabolism , Monoamine Oxidase/chemistry , Monoamine Oxidase/metabolism , Picolinic Acids/metabolism , Amino Acid Sequence , Base Sequence , Binding Sites , Cell Line , Chromatography, High Pressure Liquid , Cysteine , DNA Primers , Humans , Kidney , Kinetics , Molecular Sequence Data , Monoamine Oxidase Inhibitors/pharmacology , Mutagenesis, Site-Directed , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Peptide Mapping , Picolinic Acids/pharmacology , Polymerase Chain Reaction , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Spectrophotometry , Transfection , Valine
12.
Int J Cosmet Sci ; 17(3): 105-17, 1995 Jun.
Article in English | MEDLINE | ID: mdl-19245495

ABSTRACT

Summary Opto-thermal transient radiometry (OTTER) is a non-invasive measurement technique, well suited for in vivo skin research. Its excitation and detection wavelengths can be selected to give a high sensitivity to stratum corneum hydration. This is demonstrated with measurements of hydration changes resulting from occlusion with a neoprene cover and with a topical application of an occlusive preparation. In the former case, the hydration was found to recover to normal levels upon exposure to atmospheric conditions in a characteristic time of 15 min. In the latter case, a topical application of petroleum jelly was found to lead to a doubling of stratum corneum hydration over 2h. This ability to measure hydration changes in the presence of topical hydrating agents is thought to be a particularly valuable property of the OTTER technique. With a different choice of excitation and detection wavelengths, OTTER can be used to measure skin thickness, from the surface down to the vascular bed. This technique was used to measure a skin thickness map of the ventral surface of the forearm of a volunteer, showing distinct thickening near the wrist and ulna. Another use of this technique is the study of changes in subcutaneous blood distribution associated with erythema. As a demonstration of this, blood distribution changes brought about by the topical application of a salicylate/nicotinate preparation were studied. The main finding is that the subcutaneous blood spreads towards the surface, with the mean depth decreasing from 63 mum to 55mum.

13.
J Pharmacol Exp Ther ; 266(1): 97-105, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8101225

ABSTRACT

(-)-2,3,4a,5,6,10b-Hexahydro-7-hydroxy-2-methylbenzo(f)-quinoline 4(1H)-ethanol (Ro 41-9067) was compared with apomorphine, 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine (B-HT 920), lisuride and other dopamine (DA) receptor agonists in a series of tests designed to characterize its pharmacological activity on DA receptors. In vitro binding studies indicated that Ro 41-9067 bound selectively to DA D2 vs. D1 receptors. It also had a moderate affinity for serotonin1A and alpha-2 adrenergic receptors. Ro 41-9067 exhibited a marked agonistic component for the presynaptic DA autoreceptors. Indeed, it caused a dose-related reduction in locomotor activity over a wide dose range and prolonged periods of observation without stimulating locomotor activity, reflecting postsynaptic DA receptor activation, even at the highest doses. Ro 41-9067 inhibited the gamma-butyrolactone-induced increase in I-dopa accumulation in the rat striatum, an effect sensitive to haloperiodol. Ro 41-9067 inhibited K(+)-induced [3H]DA release and significantly reduced the striatal contents of the DA metabolites, dihydroxyphenilacetic acid and homovanillic acid. Furthermore, the compound counteracted stereotyped behavior and locomotor stimulation induced by amphetamine. Finally, Ro 41-9067 did not appear to act on postsynaptic D2 receptors because it, similarly to B-HT 920 but differently from bromocriptine, quinpirole and lisuride, did not change basal or forskolin-stimulated adenylate cyclase activity. Only at very high concentrations Ro 41-9067 increased adenylate cyclase activity, this effect being due to a D1 agonistic component.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Brain/drug effects , Dopamine Agents/pharmacology , Quinolines/pharmacology , Stereotyped Behavior/drug effects , Tetrahydronaphthalenes/pharmacology , 4-Butyrolactone/antagonists & inhibitors , Adenylyl Cyclases/metabolism , Amphetamine/antagonists & inhibitors , Animals , Apomorphine/pharmacology , Biogenic Monoamines/metabolism , Brain/metabolism , Brain/ultrastructure , Catalepsy/chemically induced , Corpus Striatum/anatomy & histology , Corpus Striatum/metabolism , Dopamine/metabolism , Dose-Response Relationship, Drug , Levodopa/metabolism , Locomotion/drug effects , Male , Motor Activity/drug effects , Perfusion , Potassium/pharmacology , Quinolines/toxicity , Rats , Rats, Wistar , Receptors, Adrenergic, alpha/metabolism , Receptors, Serotonin/metabolism , Synapses/drug effects , Synapses/physiology , Tetrahydronaphthalenes/toxicity , Time Factors , Tritium
15.
Psychopharmacology (Berl) ; 106 Suppl: S15-6, 1992.
Article in English | MEDLINE | ID: mdl-1546132

ABSTRACT

The mode of interaction of the reversible monoamine oxidase-A (MAO-A) inhibitor moclobemide with the enzyme was investigated. The inhibition of rat brain or human placenta MAO-A by moclobemide showed an initial competitive phase, with a relatively low affinity (KI = 0.2-0.4 mM). However, the potency of the inhibitor was increased with incubation time. The time-dependent component of the association of moclobemide with MAO-A followed pseudo-first order kinetics. In contrast to mechanism-based inhibitors, no indication for adduct or product formation was detected after incubation of moclobemide with the enzyme. Even though some aspects of the moclobemide interaction with MAO-A are still not completely elucidated, this compound seems to have the characteristics of a slow-binding inhibitor.


Subject(s)
Benzamides/pharmacology , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Binding Sites/drug effects , Brain/drug effects , Brain/enzymology , Female , Humans , Kinetics , Mitochondria/drug effects , Mitochondria/enzymology , Moclobemide , Placenta/enzymology , Pregnancy , Tyramine/metabolism
16.
Mol Pharmacol ; 37(3): 358-66, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2314388

ABSTRACT

The novel reversible and selective inhibitor of monoamine oxidase-A (MAO-A) Ro 41-1049 [N-(2-aminoethyl)-5-(m-fluorophenyl)-4-thiazole carboxamide HCl] shows inhibition characteristics similar to those of the structurally related reversible MAO-B inhibitors Ro 16-6491 and Ro 19-6327. In the present study, tritiated Ro 41-1049 was used as a high affinity ligand to study the binding characteristics of this inhibitor to MAO-A and its interactions with the enzyme. An homogeneous population of high affinity binding sites for [3H]Ro 41-1049 was found in membrane preparations from human frontal cortex and placenta (Kd = 16.5 +/- 1.4 and 64.4 +/- 19.2 nM, respectively). In frontal cortex the Bmax value for [3H]Ro 41-1049 (2.6 +/- 0.4 pmol/mg of protein) was about one third of the Bmax calculated for the MAO-B-selective ligand [3H]Ro 16-6491. The density of [3H]Ro 41-1049 binding sites in human placenta varied greatly in the different tissue samples investigated, showing an average Bmax of 101.7 +/- 36.5 pmol/mg of protein. Apparent binding equilibrium was reached after 1 hr of incubation at 37 degrees. At this temperature the binding was reversible, with a dissociation t 1/2 of about 35 min. At lower temperatures the radioactivity dissociation was much slower. Among the various drugs tested, only inhibitors of MAO-A were able to effectively prevent [3H]Ro 41-1049 specific binding. As previously reported for the MAO-B ligands [3H]Ro 16-6491 and [3H]Ro 19-6327, the analysis of the membrane-bound radioactivity showed that [3H]Ro 41-1049 was entirely recovered in the form of its aldehyde derivative, indicating that Ro 41-1049 was deaminated by MAO-A. The existence of a Ro 41-1049 adduct reversibly bound to the enzyme active site might explain the inhibition mechanism of this compound. The exposure of the radioligand-enzyme complex to NaBH3CN at pH 4.5 caused the irreversible covalent incorporation of about 70% of the specifically bound radioactivity into a 60-kDa polypeptide. This incorporation was dependent on the pH and on the amount of NaBH3CN added. The presence of MAO-A- but not MAO-B-selective inhibitors prevented the covalent incorporation of [3H]Ro 41-1049. The present results indicate that [3H]Ro 41-1049 is incorporated into a subunit of MAO-A, in the presence of NaBH3CN, and modifies a protein domain that is essential for the enzyme activity.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Monoamine Oxidase Inhibitors/metabolism , Monoamine Oxidase/metabolism , Thiazoles/metabolism , Affinity Labels , Binding Sites , Binding, Competitive , Cerebral Cortex/metabolism , Chromatography, High Pressure Liquid , Humans , In Vitro Techniques , Molecular Weight , Placenta/metabolism , Structure-Activity Relationship , Trypsin/pharmacology
17.
J Neural Transm Suppl ; 29: 279-92, 1990.
Article in English | MEDLINE | ID: mdl-2193111

ABSTRACT

This study describes the serendipitous discovery of moclobemide, a short-acting MAO-A inhibitor which is in an advanced stage of clinical development as an antidepressant. The short duration of action of this MAO inhibitor containing a morpholine ring moiety is due to the complete reversibility (probably by metabolism of the inhibitory molecular species) of MAO-A inhibition. Since moclobemide is much more effective in vivo than expected from its in vitro activity, investigations to identify a possible metabolite(s) more active as MAO-A inhibitor than the parent compound were carried out. The study of the MAO inhibitory characteristics of several known and putative moclobemide metabolites did not allow the identification of a potent MAO-A inhibitor but led to the discovery of Ro 16-6491, a potent MAO-B inhibitor of novel chemical structure. Systematic chemical modification of the aromatic ring system of Ro 16-6491 finally provided Ro 19-6327 and Ro 41-1049 which are highly selective and reversible inhibitors of MAO-B and MAO-A, respectively. Tritiated derivatives of Ro 19-6327 and Ro 41-1049 were used in binding studies to elucidate their mechanisms of action and to study their cellular distribution by quantitative enzyme radioautography.


Subject(s)
Benzamides/pharmacology , Brain/enzymology , Enzyme Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Picolinic Acids/pharmacology , Thiazoles/pharmacology , Animals , Brain/drug effects , Moclobemide , Rats
19.
Phys Med Biol ; 35(1): 95-102, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2304972

ABSTRACT

Opto-thermal transient emission radiometry (OTTER) provides a convenient means for in vivo and in situ monitoring of human or animal skin properties and surface concentrations of topically applied substances, such as drugs and cosmetics. This is illustrated with measurements on the rates of disappearance from skin of a number of commercial sunscreen preparations. The break-up of the physical structure of creams on skin can also be monitored through dynamic phase change phenomena, induced by a laser pulse.


Subject(s)
Monitoring, Physiologic/methods , Skin/drug effects , Sunscreening Agents/administration & dosage , Administration, Cutaneous , Humans , Lasers , Monitoring, Physiologic/instrumentation , Optics and Photonics/instrumentation , Sunscreening Agents/standards
20.
Am J Obstet Gynecol ; 162(1): 110-4, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2405672

ABSTRACT

Flow velocity waveforms of the uteroplacental arteries were analyzed at 20 and 24 weeks of gestation, by means of duplex pulsed Doppler ultrasonography, in 93 women at risk for preeclampsia or intrauterine growth retardation. The ability of an elevated resistance index to predict these conditions was tested. At 20 and 24 weeks an abnormal resistance index was significantly associated with intrauterine growth retardation but not with preeclampsia, with or without proteinuria. A low fetal abdominal circumference at 20 or 24 weeks or an increasing maternal plasma uric acid concentration at 24 weeks was as predictive as an elevated resistance index. In a second group of 43 women, screened in the same way, the only association was of an elevated resistance index at 20 weeks with intrauterine growth retardation. Although elevated resistance indices occur more commonly in women who develop intrauterine growth retardation and/or preeclampsia, the correlation is not close enough to be clinically useful as a screening test.


Subject(s)
Fetal Growth Retardation/diagnosis , Placenta/blood supply , Pre-Eclampsia/diagnosis , Ultrasonography , Uterus/blood supply , Blood Flow Velocity , Female , Fetal Growth Retardation/physiopathology , Humans , Pre-Eclampsia/physiopathology , Predictive Value of Tests , Pregnancy , Uric Acid/blood , Vascular Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...